Dr. Reddy’s Gets Abatacept Biosimilar Approval The Story: Dr. Reddy’s has received CDSCO approval for its abatacept biosimilar in India for rheumatoid arthritis and psoriatic arthritis. The Take: The ...
Key Highlights: Implications: For Novartis India, bringing these brands back in‑house supports a more controlled go‑to‑market under new PE ownership and aligns with its plan to insta...
